Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Mechanism on Blood Pressure in T2D
NCT01755572Phase 4Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and isolated systolic hypertension (ISH) comparing Liraglutide First with Placebo First (2 arms). Primary endpoint: Plasma Atrial Natriuretic Peptide at 21 days. Started Jan 2013; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT01755572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755572.